Avricore Health Inc.
AVCR.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -287.66% | -432.41% | -68.40% | 185.39% | 120.61% |
| Total Depreciation and Amortization | -5.31% | 4.28% | 0.00% | -12.84% | 1.45% |
| Total Amortization of Deferred Charges | 19.05% | -4.55% | 15.79% | -69.35% | -- |
| Total Other Non-Cash Items | 181.89% | 20,558.33% | -90.77% | -88.00% | -52.27% |
| Change in Net Operating Assets | 8.00% | 78.09% | -239.32% | 221.88% | -300.60% |
| Cash from Operations | 40.34% | 2,079.01% | -97.31% | 65.22% | 32.49% |
| Capital Expenditure | 92.31% | -112.93% | 59.15% | 77.50% | -26.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -614.29% | 89.06% | -14.29% | 56.92% | -12,900.00% |
| Cash from Investing | 82.44% | -69.26% | 52.56% | 76.48% | -33.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | -66.67% | 5,150.00% | -93.59% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -67.53% | 5,400.00% | 106.54% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 52.46% | 892.79% | -109.12% | 374.82% | -34.30% |